|
E2F7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.27100552305137E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.7249999996809E-07 |
| Normal-vs-Stage2 |
6.124000E-03 |
| Normal-vs-Stage3 |
1.99582999999004E-05 |
| Normal-vs-Stage4 |
3.98460000000656E-05 |
| Stage1-vs-Stage2 |
3.853400E-01 |
| Stage1-vs-Stage3 |
3.524400E-02 |
| Stage1-vs-Stage4 |
2.122400E-03 |
| Stage2-vs-Stage3 |
5.173000E-01 |
| Stage2-vs-Stage4 |
2.246200E-02 |
| Stage3-vs-Stage4 |
5.406000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.62749821899888E-11 |
| Normal-vs-AfricanAmerican |
1.180470E-04 |
| Normal-vs-Asian |
2.199400E-01 |
| Caucasian-vs-AfricanAmerican |
1.859810E-03 |
| Caucasian-vs-Asian |
3.836400E-01 |
| AfricanAmerican-vs-Asian |
2.988800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.66239960370285E-10 |
| Normal-vs-Female |
3.96250000034293E-07 |
| Male-vs-Female |
1.950440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.140300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.53899999966178E-07 |
| Normal-vs-Age(61-80Yrs) |
5.29600000520603E-08 |
| Normal-vs-Age(81-100Yrs) |
2.125800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.927800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.969200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.531200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.635800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.639600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.411400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.460460E-03 |
| Normal-vs-Grade 2 |
5.74180000212365E-08 |
| Normal-vs-Grade 3 |
4.73660000110954E-08 |
| Normal-vs-Grade 4 |
6.47859999999278E-05 |
| Grade 1-vs-Grade 2 |
1.109820E-01 |
| Grade 1-vs-Grade 3 |
1.467670E-02 |
| Grade 1-vs-Grade 4 |
9.017400E-04 |
| Grade 2-vs-Grade 3 |
1.654150E-01 |
| Grade 2-vs-Grade 4 |
2.282800E-03 |
| Grade 3-vs-Grade 4 |
6.296900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.91497999999513E-05 |
| Normal-vs-ccB subtype |
2.02790000014552E-07 |
| ccA subtype-vs-ccB subtype |
1.979230E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.70599999472066E-08 |
| Normal-vs-N1 |
6.738300E-03 |
| N0-vs-N1 |
1.302310E-02 |
|
|
